High-activity Natural Killer immunotherapy

· Fuda Cancer Hospital, Guangzhou

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for High-activity Natural Killer immunotherapy, covering 2019-09-12 to 2019-09-12. Get the full timeline:

Most recent: Clinical Trial Update: High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer [Phase 1, Phase 2]